Transcranial Electrical Stimulation for Auditory Hallucinations

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Beth Israel Deaconess Medical Center, Boston, MAAuditory Hallucinations+1 MoreTranscranial Electrical Stimulation - Device
Eligibility
18 - 50
All Sexes
What conditions do you have?
Select

Study Summary

This trial will test whether or not brain stimulation can help improve hallucinations in people with different neurological and psychiatric illnesses.

Eligible Conditions
  • Hallucinations
  • Auditory Hallucinations
  • Psychosis

Treatment Effectiveness

Study Objectives

3 Primary · 11 Secondary · Reporting Duration: Change from baseline to month follow-up

Change from baseline to month follow-up
7-item Auditory Hallucinations Rating Scale (AHRS)
Auditory Steady state evoked potential
Biological motion
Brief Assessment of Cognition (BACS)
Cross Modal Steady state evoked potential
Global assessment of function (GAF)
Montgomery-Asberg Depression Rating Scale (MADRS)
Neurological Evaluation Scale; Sensory Integration
Positive and Negative Syndrome Scale (PANSS)
Resting State EEG
Steady state visual evoked potential
Symptom Checklist-90
University of Miami Parkinson's Disease Hallucinations Questionnaire (UM-PDHQ)
Young Mania Rating Scale (YMRS)

Trial Safety

Trial Design

2 Treatment Groups

Active Stimulation with TDCS
1 of 2
SHAM Stimulation
1 of 2

Experimental Treatment

Non-Treatment Group

20 Total Participants · 2 Treatment Groups

Primary Treatment: Transcranial Electrical Stimulation · Has Placebo Group · N/A

Active Stimulation with TDCS
Device
Experimental Group · 1 Intervention: Transcranial Electrical Stimulation · Intervention Types: Device
SHAM Stimulation
Device
ShamComparator Group · 1 Intervention: Transcranial Electrical Stimulation · Intervention Types: Device
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Transcranial Electrical Stimulation
2019
Completed Early Phase 1
~20

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: change from baseline to month follow-up

Who is running the clinical trial?

Beth Israel Deaconess Medical CenterLead Sponsor
782 Previous Clinical Trials
846,065 Total Patients Enrolled

Eligibility Criteria

Age 18 - 50 · All Participants · 5 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You are currently seeing, hearing, or feeling things that aren't really there.
You have not received tES/TMS treatments recently.